학술논문
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant.
Document Type
Article
Source
Human Vaccines & Immunotherapeutics; 2024, Vol. 20 Issue 1, p1-6, 6p
Subject
Language
ISSN
21645515